Default: Trends in Biotechnology

ISSN: 0167-7799

Journal Home

Journal Guideline

Trends in Biotechnology Q1 Unclaimed

Elsevier Ltd. Netherlands
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Trends in Biotechnology is a journal indexed in SJR in Biotechnology and Bioengineering with an H index of 207. It has an SJR impact factor of 3,096 and it has a best quartile of Q1. It is published in English.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

- €

Gold OA

-

Green OA

- €

Non OA

Metrics

Trends in Biotechnology

3,096

SJR Impact factor

207

H Index

140

Total Docs (Last Year)

372

Total Docs (3 years)

8368

Total Refs

3918

Total Cites (3 years)

310

Citable Docs (3 years)

11,22

Cites/Doc (2 years)

59,77

Ref/Doc


Best articles

A broad perspective on protein engineering and complementary technologies

View more

A catalog with no hopes

View more

A glimpse at changes to come?

View more

Accessing new resources for drug discovery

View more

Advances in antisense efficacy and delivery

View more

Agricultural bug sequence

View more

Alzheimers vaccine?

View more

Ambiguities in the preclinical quality assessment of microparticulate vaccines

View more

Answering the question: 'Why did biocatalysis in organic media not take off in the 1930s?'

View more

Be still my beating heart

View more

Biocatalysis in organic chemistry (Part I): past and present

View more

Biocatalysis in organic chemistry (Part II): present and future

View more
SHOW MORE ARTICLES

Biocavity lasers for biomedicine

View more

Bioinformatics in the pre- and post-genomic eras

View more

Bioinformatics meets data mining: time to dance?

View more

Biotechnology in European society

View more

Biotechnology, inquiry, and public education

View more

Biotechnology, IPRs and Agriculture

View more

Breeding of Escherichia coli based on colour

View more

Bridging the gap with ORF ESTs

View more

Californian biotech power struggle

View more

Carbohydrate bioengineering

View more

Commercialization of gene therapy - the evolution of licensing and rights issues

View more

Conquering the proteome: complexity, cooperation and commerce

View more

Comments

No comments ... Be the first to comment!